MarketPulse

clinical trial safety

6 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Soleno Therapeutics Faces Class Action Over DCCR Safety Disclosures

Soleno Therapeutics faces class action lawsuit alleging false statements about DCCR drug safety. Lead plaintiff deadline: May 5, 2026.
SLNOclass action lawsuitinvestor losses
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Soleno Therapeutics Faces Securities Lawsuit Over Alleged Safety Data Concealment

Securities class action filed against $SLNO over alleged misstatements about Prader-Willi drug safety risks. Lead plaintiff deadline set for May 5, 2026.
SLNOsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Class Action Targets Soleno Therapeutics Over DCCR Safety Disclosure Gap

Soleno Therapeutics faces class action lawsuit alleging false safety disclosures about DCCR drug candidate for Prader-Willi syndrome.
SLNOclass action lawsuitinvestor losses
GlobeNewswire Inc.GlobeNewswire Inc.··Kahn Swick & Foti, Llc

Soleno Therapeutics Faces Securities Fraud Lawsuit Over Undisclosed DCCR Safety Risks

Soleno Therapeutics faces securities fraud lawsuit alleging undisclosed DCCR safety risks. Investors must file by May 5, 2026.
IBRXSMCISLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Soleno Therapeutics Faces Securities Suit Over Undisclosed Drug Safety Risks

Rosen Law Firm alerts $SLNO investors about class action lawsuit alleging false statements regarding DCCR drug safety. Lead plaintiff deadline: May 5, 2026.
MREOCOTYSLNOsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Soleno Therapeutics Faces Class Action Over Alleged PWS Drug Safety Misstatements

Class action lawsuit filed against $SLNO alleging false statements about DCCR safety concerns and commercial viability for Prader-Willi syndrome treatment.
SLNOsecurities fraudclass action lawsuit